Shares of AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Get Free Report) traded up 2.3% on Thursday . The company traded as high as $11.09 and last traded at $11.09. 2,501 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 13,993 shares. The stock had previously closed at $10.84.
AdvisorShares Psychedelics ETF Stock Performance
The company’s 50-day moving average price is $12.29 and its 200 day moving average price is $11.93.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in AdvisorShares Psychedelics ETF stock. Spire Wealth Management acquired a new position in AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 2,484 shares of the company’s stock, valued at approximately $27,000.
AdvisorShares Psychedelics ETF Company Profile
The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.
Read More
- Five stocks we like better than AdvisorShares Psychedelics ETF
- 3 Warren Buffett Stocks to Buy Now
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- Profitably Trade Stocks at 52-Week Highs
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Differences Between Momentum Investing and Long Term Investing
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for AdvisorShares Psychedelics ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvisorShares Psychedelics ETF and related companies with MarketBeat.com's FREE daily email newsletter.
